MacroGenics, Inc. (MGNX) — Stock Score Summary

MacroGenics, Inc. (MGNX) has a MoatMap StockRank of 45/100 based on Quality (21/100), Value (41/100), and Momentum (69/100) factor scores. The current signal is HOLD. MacroGenics is a clinical-stage biopharmaceutical company. It lacks the predictable cash flows, high ROIC, and established moats of a quality compounder, making it highly speculative.

MacroGenics, Inc. is a clinical-stage biotechnology company focused on discovering and developing innovative antibody-based therapeutics for cancer and other serious diseases. The company utilizes proprietary DART and TRIDENT platforms to create novel bispecific antibodies with enhanced therapeutic potential. MacroGenics aims to address unmet medical needs through its pipeline of differentiated immuno-oncology and autoimmune drug candidates.

Key Financial Metrics

Price$3.91
Market Cap$268M
P/E (Forward)-3.01
Price/Book12.72
Return on Equity-140.3%
Return on Invested Capital-31.2%
Debt/Equity172.23
Gross Margin-19.2%
Operating Margin-161.0%
Revenue Growth57.5%
Free Cash Flow$12M

MacroGenics, Inc. operates in the Biotechnology industry, part of the Healthcare sector (United States).

Frequently Asked Questions

What is MacroGenics, Inc.’s (MGNX) StockRank?
MoatMap’s StockRank for MacroGenics, Inc. (MGNX) is 45/100, with a Hold signal. It is a composite of Quality (21), Value (41), and Momentum (69) factor ranks across MoatMap’s 19,000+ stock universe.
Does MacroGenics, Inc. have an economic moat?
MacroGenics, Inc. (MGNX) has a Quality factor score of 21/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is MacroGenics, Inc. a buy, hold, or sell?
MoatMap’s current signal for MacroGenics, Inc. (MGNX) is Hold, based on a StockRank of 45/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is MacroGenics, Inc. in?
MacroGenics, Inc. (MGNX) operates in the Healthcare sector, specifically the Biotechnology industry (United States).
Browse all ranked stocksMGNX deep dive reportAI ChampionsHow we score stocksSense-check another stock